Cited by 30Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Infections and Studies

Host–pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella

Open access
Garcia-Bustos, Victor, Pemán, Javier, Ruiz-Gaitán, Alba, Cabañero-Navalon, Marta Dafne, Cabanilles-Boronat, Ana, Fernández-Calduch, María, Marcilla-Barreda, Lucía, Sigona-Giangreco, Ignacio A. +3 more·2022·Emerging Microbes & Infections

Abstract

Candida auris has globally emerged as a multidrug-resistant fungus linked to healthcare-associated outbreaks. There is still limited evidence on its virulence, pathogenicity determinants, and complex host–pathogen interactions. This study analyzes the in vivo fungal behaviour, immune response, and host–pathogen interactions upon C. auris infection compared to C. albicans and C. parapsilosis in G. mellonella. This was performed by immunolabelling fungal structures and larval plasmatocytes and using a quantitative approach incorporating bioinformatic morphometric techniques into the study of microbial pathogenesis. C. auris presents a remarkably higher immunogenic activity than expected at its moderate degree of tissue invasion. It induces a greater inflammatory response than C. albicans and C. parapsilosis at the expense of plasmatocyte nodule formation, especially in non-aggregative strains. It specifically invades the larval respiratory system, in a pattern not previously observed in other Candida species, and presents inter-phenotypic tissue tropism differences. C. auris filaments in vivo less frequently than C. albicans or C. parapsilosis mostly through pseudohyphal growth. Filamentation might not be a major pathogenic determinant in C. auris, as less virulent aggregative phenotypes form pseudohyphae to a greater extent. C. auris has important both interspecific and intraspecific virulence and phenotype heterogeneity, with aggregative phenotypes of C. auris sharing characteristics with low pathogenic species such as C. parapsilosis. Our work suggests that C. auris owns an important morphogenetic plasticity that distinguishes it from other yeasts of the genus. Routine phenotypic identification of aggregative or non-aggregative phenotypes should be performed in the clinical setting as it may impact patient management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/22221751.2021.2017756

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Filamentation of C. auris has a limited impact on virulence, while aggregation has been associated with decreased virulence.

    “This is in line with previous observations showing that filamentation of C. auris has a limited impact on virulence, while aggregation has been associated with decreased virulence (17, 46).”

    From Ume6-dependent pathways of morphogenesis and biofilm formation in <i>Candida auris</i> (2024) · cites this paper as [46]

    The Discussion describes aggregative C. auris phenotypes as less virulent and observes that they tend to form more pseudohyphae. It says filamentation *might not* be a major pathogenic determinant and *does not seem* as decisive as previously assumed; the claim presents its limited impact on virulence more definitively. Page numbers are not supplied in our copy. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Non-aggregative variants are more virulent than aggregative variants in Galleria models.

    “Non-aggregative variants were more virulent than aggregative variants in Galleria models (17, 24, 43, 46, 48).”
  • Filamentation is an important virulence trait of C. albicans, but its pathogenic role in C. auris is less obvious.

    “While filamentation is an important virulence trait of C. albicans, its pathogenic role in C. auris is less obvious (20, 43, 46).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. [4]Chakrabarti A, Sood P. On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points. J Med Microbiol. 2021; 70(3): 001318. PMC8346726 33599604
  2. [5]Eyre D, Sheppard A, Madder H, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med. 2018; 379: 1322– 1331. 30281988
  3. [6]Ruiz-Gaitán A, Moret AM, Tasias-Pitarch M, et al. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses. 2018; 61(7): 498– 505. 29655180
  4. [7]Ruiz-Gaitán A, Martínez H, Moret AM, et al. Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients. Expert Rev Anti Infect Ther. 2019; 17(4): 295– 305. 30922129
  5. [8]Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017; 64(2): 134– 140. Erratum in: Clin Infect Dis. 2018;67(6):987. 27988485 PMC5215215
  6. [9]Schelenz S, Hagen F, Rhodes J, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016; 5: 5. 27777756 PMC5069812
  7. [12]Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen candida auris and other key pathogenic Candida species. mSphere. 2016; 1(4): e00189– 16. 27547827 PMC4990711
  8. [13]Sherry L, Ramage G, Kean R, et al. Biofilm-Forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis. 2017; 23(2): 328– 331. 28098553 PMC5324806
  9. [14]Romera D, Aguilera-Correa JJ, García-Coca M, et al. The Galleria mellonella infection model as a system to investigate the virulence of Candida auris strains. Pathog Dis. 2020; 78(9): ftaa067. 33098293
  10. [15]Muñoz JE, Ramirez LM, Dias LDS, et al. Pathogenicity levels of Colombian strains of Candida auris and Brazilian strains of Candida haemulonii species complex in both murine and Galleria mellonella experimental models. J Fungi (Basel). 2020; 6(3): 104. PMC7558079 32664191
  11. [16]Garcia-Bustos V, Ruiz-Saurí A, Ruiz-Gaitán A, et al. Characterization of the differential pathogenicity of Candida auris in a Galleria mellonella infection model. Microbiol Spectr. 2021: e0001321. 34106570 PMC8552516
  12. [17]Carvajal SK, Alvarado M, Rodríguez YM, et al. Pathogenicity assessment of Colombian strains of Candida auris in the Galleria mellonella invertebrate model. J Fungi (Basel). 2021; 7(6): 401. 34063862 PMC8223996
  13. [18]Hernando-Ortiz A, Mateo E, Perez-Rodriguez A, et al. Virulence of Candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models. Virulence. 2021; 12(1): 1063– 1075. 33843456 PMC8043173
  14. [19]Forgács L, Borman AM, Prépost E, et al. Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model. Emerg Microbes Infect. 2020; 9(1): 1160– 1169. 32486923 PMC7448943
  15. [20]Larkin E, Hager C, Chandra J, et al. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother. 2017; 61(5): e02396– 16. 28223375 PMC5404565
  16. [21]Singh R, Kaur M, Chakrabarti A, et al. Biofilm formation by Candida auris isolated from colonising sites and candidemia cases. Mycoses. 2019; 62(8): 706– 709. 31132181
  17. [22]Yue H, Bing J, Zheng Q, et al. Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch. Emerg Microbes Infect. 2018; 7(1): 188. 30482894 PMC6258701
  18. [23]Torres SR, Pichowicz A, Torres-Velez F, et al. Impact of Candida auris infection in a neutropenic murine model. Antimicrob Agents Chemother. 2020; 64(3): e01625– 19. 31818824 PMC7038241
  19. [24]Fakhim H, Vaezi A, Dannaoui E, et al. Comparative virulence of candida auris with candida haemulonii, candida glabrata and candida albicans in a murine model. Mycoses. 2018; 61(6): 377– 382. 29460345
  20. [25]Charroux B, Royet J. Elimination of plasmatocytes by targeted apoptosis reveals their role in multiple aspects of the Drosophila immune response. Proc Natl Acad Sci U S A. 2009; 106(24): 9797– 9802. 19482944 PMC2700997
  21. [26]Ruiz-Saurí A, García-Bustos V, Granero E, et al. Distribution of vascular patterns in different subtypes of renal cell carcinoma. A morphometric study in two distinct types of blood vessels. Pathol Oncol Res. 2018; 24(3): 515– 524. 28669081
  22. [27]Garcia-Bustos V, Sebastian R, Izquierdo M, Rios-Navarro C, Bodí V, Chorro FJ, Ruiz-Sauri A. Changes in the spatial distribution of the Purkinje network after acute myocardial infarction in the pig. PLoS One. 2014; 14(2): e0212096. PMC6370232 30742681
  23. [28]Bellemain E, Carlsen T. Antinociceptive effect of geranylgeraniol and 6α, 7β-dihydroxyvouacapan-17β-oate methyl ester isolated from Pterodon pubescens benth. BMC Pharmacol. 2010; 10: 1– 9. 20055987 PMC2817697
  24. [29]Bentz ML, Sexton DJ, Welsh RM, et al. Phenotypic switching in newly emerged multidrug-resistant pathogen Candida auris. Med Mycol. 2018; 57(5): 636– 638. 30329075
  25. [30]Fan S, Yue H, Zheng Q, et al. Filamentous growth is a general feature of Candida auris clinical isolates. Med Mycol. 2021; 59(7): 734– 740. 33485272 PMC8257410
  26. [31]ElBaradei A. A decade after the emergence of Candida auris: what do we know? Eur J Clin Microbiol Infect Dis. 2020; 39(9): 1617– 1627. 32297040
  27. [33]Ruiz G B, Ross ZK, Gow NAR, et al. Pseudohyphal growth of the emerging pathogen Candida auris is triggered by genotoxic stress through the S phase checkpoint. mSphere. 2020; 5(2): e00151– 20. 32161147 PMC7067593
  28. [34]Rossoni RD, de Barros PP, Mendonça IDC, et al. The postbiotic activity of Lactobacillus paracasei 28.4 against Candida auris. Front Cell Infect Microbiol. 2020; 10: 397. 32850495 PMC7417517
  29. [35]Gago S, García-Rodas R, Cuesta I, et al. Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella. Virulence. 2014; 5(2): 278– 285. 24193303 PMC3956503
  30. [36]García-Carnero LC, Clavijo-Giraldo DM, Gómez-Gaviria M, et al. Early virulence predictors during the Candida species-Galleria mellonella interaction. J Fungi (Basel). 2020; 6(3): 152. PMC7559698 32867152
  31. [37]Essig F, Hünniger K, Dietrich S, et al. Human neutrophils dump Candida glabrata after intracellular killing. Fungal Genet Biol. 2015; 84: 37– 40. 26385824
  32. [38]Asai M, Sheehan G, Li Y, et al. Innate immune responses of Galleria mellonella to mycobacterium bovis BCG challenge identified using proteomic and molecular approaches. Front Cell Infect Microbiol. 2021; 11: 619981. 10.3389/fcimb.2021.619981 33634038 PMC7900627 · DOI

Cited by

Sorted by citations

Authors
Garcia-Bustos, V., Pemán, J., Ruiz-Gaitán, A., Cabañero-Navalon, M. D., Cabanilles-Boronat, A., Fernández-Calduch, M., Marcilla-Barreda, L., Sigona-Giangreco, I. A., Salavert, M., Tormo-Mas, M. Á., & Ruiz-Saurí, A.
Affiliations
  • University and Polytechnic La Fe Hospital
  • Hospital Universitari i Politècnic La Fe (ES)
  • Severe Infection Research Group, Health Research Institute La Fe
  • Universitat de València (ES)
  • University of Valencia
Venue
Emerging Microbes & Infections
Published
2021-12-21
Volume
11
Issue
1
Pages
136-146
ISSN
2222-1751 (ISSN-L)
OpenAlex
W4200033886
Cited by
30
References
5
Citations by year
2026: 5 · 2025: 8 · 2024: 7 · 2023: 6 · 2022: 4
FWCI
1.35
Type
journal article
Language
en
Open access
Locations
  • Emerging Microbes & Infections (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Instituto de Salud Carlos III (PI17/01538)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
Candida auris, host-pathogen interaction, Galleria mellonella, fungal virulence, plasmatocytes, inflammation, tissue invasion, filamentation, pseudohyphal growth, Candida albicans, Candida parapsilosis, morphometrics, fungal morphogenesis
MeSH terms
Candida parapsilosis, Candida auris, Animals, Candida albicans, Hemocytes, Hemolymph, Immunity, Larva, Moths, Respiratory System, Virulence, Host-Pathogen Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review